ATG16L1 and cancer: Additionally, BIRC5 negatively modulates the protein stability of ATG7 and physically binds to the ATG12–ATG5 conjugate, thereby preventing formation of the ATG12–ATG5–ATG16L1 protein complex in human cancer and suggesting that BIRC5 can directly regulate autophagy in cancer cells [58].